Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$16.46 - $19.99 $132,223 - $160,579
8,033 Added 52.6%
23,305 $383,000
Q2 2023

Aug 04, 2023

BUY
$17.23 - $21.71 $216,650 - $272,981
12,574 Added 466.05%
15,272 $305,000
Q1 2023

Apr 27, 2023

BUY
$18.08 - $24.55 $38,890 - $52,807
2,151 Added 393.24%
2,698 $51,000
Q4 2022

Feb 02, 2023

SELL
$20.4 - $24.73 $13,035 - $15,802
-639 Reduced 53.88%
547 $12,000
Q3 2022

Nov 04, 2022

BUY
$22.29 - $35.04 $26,435 - $41,557
1,186 New
1,186 $31,000
Q2 2022

Aug 03, 2022

SELL
$19.35 - $35.04 $6,250 - $11,317
-323 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$24.62 - $34.31 $7,189 - $10,018
292 Added 941.94%
323 $10,000
Q4 2021

Feb 23, 2022

BUY
$30.19 - $40.28 $935 - $1,248
31 New
31 $1,000
Q2 2021

Aug 12, 2021

SELL
$32.46 - $40.48 $12,497 - $15,584
-385 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$33.61 - $49.95 $1.55 Million - $2.31 Million
-46,247 Reduced 99.17%
385 $13,000
Q4 2020

Feb 02, 2021

BUY
$26.52 - $49.35 $1.22 Million - $2.27 Million
46,036 Added 7724.16%
46,632 $2.12 Million
Q3 2020

Oct 14, 2020

SELL
$27.01 - $40.26 $312,073 - $465,164
-11,554 Reduced 95.09%
596 $16,000
Q2 2020

Jul 13, 2020

SELL
$27.75 - $43.44 $39,266 - $61,467
-1,415 Reduced 10.43%
12,150 $447,000
Q1 2020

Apr 29, 2020

BUY
$21.5 - $54.2 $59,641 - $150,350
2,774 Added 25.71%
13,565 $439,000
Q4 2019

Feb 05, 2020

BUY
$34.54 - $44.87 $361,392 - $469,474
10,463 Added 3189.94%
10,791 $442,000
Q3 2019

Oct 15, 2019

SELL
$31.84 - $50.88 $36,807 - $58,817
-1,156 Reduced 77.9%
328 $11,000
Q2 2019

Jul 26, 2019

BUY
$42.0 - $59.29 $62,328 - $87,986
1,484 New
1,484 $76,000
Q2 2018

Jul 30, 2018

SELL
$27.2 - $74.35 $115,654 - $316,136
-4,252 Closed
0 $0
Q1 2018

Apr 26, 2018

SELL
$24.05 - $37.5 $75,156 - $117,187
-3,125 Reduced 42.36%
4,252 $126,000
Q4 2017

Jan 10, 2018

BUY
$26.0 - $34.6 $191,802 - $255,244
7,377
7,377 $245,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $460M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.